DOI QR코드

DOI QR Code

Percutaneous Pulmonary Valve Implantation

  • Lee, Young-Seok (Division of Pediatric Cardiology, Department of Pediatrics, Dong-A University Hospital) ;
  • Lee, Hyoung-Doo (Heart Center, Pusan National University Children's Hospital)
  • Published : 2012.10.31

Abstract

Pulmonary regurgitation (PR) is a frequent sequelae after repair of tetralogy of Fallot, pulmonary atresia, truncus arteriosus, Rastelli and Ross operation. Due to patient growth and conduit degeneration, these conduits have to be changed frequently due to regurgitation or stenosis. However, morbidity is significant in these repeated operations. To prolong conduit longevity, baremetal stenting in the right ventricular outflow tract (RVOT) obstruction has been performed. Stenting the RVOT can reduce the right ventricular pressure and symptomatic improvement, but it causes PR with detrimental effects on the right ventricle function and risks of arrhythmia. Percutaneous pulmonary valve implantation has been shown to be a safe and effective treatment for patients with pulmonary valve insufficiency, or stenotic RVOTs.

Keywords

References

  1. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-5. https://doi.org/10.1016/S0140-6736(00)02844-0
  2. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 2000;102:813-6. https://doi.org/10.1161/01.CIR.102.7.813
  3. Bonhoeffer P, Boudjemline Y, Qureshi SA, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol 2002;39:1664-9. https://doi.org/10.1016/S0735-1097(02)01822-3
  4. Lauten A, Hoyme M, Figulla HR. Severe pulmonary regurgitation after tetralogy-of-Fallot repair: transcatheter treatment with the Edwards SAPIEN XT heart valve. Heart 2012;98:623-4. https://doi.org/10.1136/heartjnl-2011-301399
  5. Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol 2011;58:2248-56. https://doi.org/10.1016/j.jacc.2011.07.040
  6. Boone RH, Webb JG, Horlick E, et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 2010;75:286-94. https://doi.org/10.1002/ccd.22250
  7. Marianeschi SM, Santoro F, Ribera E, et al. Pulmonary valve implantation with the new Shelhigh Injectable Stented Pulmonic Valve. Ann Thorac Surg 2008;86:1466-71; discussion 1472. https://doi.org/10.1016/j.athoracsur.2008.06.085
  8. Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv 2006;67:659-62. https://doi.org/10.1002/ccd.20753
  9. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-82. https://doi.org/10.1016/j.amjcard.2004.11.037
  10. Batra AS, McElhinney DB, Wang W, et al. Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial. Am Heart J 2012;163:280-7. https://doi.org/10.1016/j.ahj.2011.10.017
  11. Lurz P, Nordmeyer J, Giardini A, et al. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J Am Coll Cardiol 2011;57:724-31. https://doi.org/10.1016/j.jacc.2010.07.056
  12. Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J 2011;32:1260-5. https://doi.org/10.1093/eurheartj/ehq520
  13. Peng LF, McElhinney DB, Nugent AW, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation 2006;113:2598-605. https://doi.org/10.1161/CIRCULATIONAHA.105.607127
  14. Khambadkone S, Bonhoeffer P. Nonsurgical pulmonary valve replacement: why, when, and how? Catheter Cardiovasc Interv 2004;62:401-8. https://doi.org/10.1002/ccd.20122
  15. Khambadkone S. Percutaneous pulmonary valve implantation. Ann Pediatr Cardiol 2012;5:53-60. https://doi.org/10.4103/0974-2069.93713
  16. Nordmeyer J, Khambadkone S, Coats L, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 2007;115:1392-7. https://doi.org/10.1161/CIRCULATIONAHA.106.674259
  17. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol 2009;54:1722-9. https://doi.org/10.1016/j.jacc.2009.06.034
  18. Demkow M, Biernacka EK, Spiewak M, et al. Percutaneous pulmonary valve implantation preceded by routine prestenting with a bare metal stent. Catheter Cardiovasc Interv 2011;77:381-9. https://doi.org/10.1002/ccd.22700
  19. Nordmeyer J, Lurz P, Khambadkone S, et al. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart 2011;97:118-23. https://doi.org/10.1136/hrt.2010.198382
  20. Momenah TS, El Oakley R, Al Najashi K, Khoshhal S, Al Qethamy H, Bonhoeffer P. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009;53:1859-63. https://doi.org/10.1016/j.jacc.2008.08.061
  21. Lurz P, Nordmeyer J, Muthurangu V, et al. Comparison of bare metal stenting and percutaneous pulmonary valve implantation for treatment of right ventricular outflow tract obstruction: use of an x-ray/magnetic resonance hybrid laboratory for acute physiological assessment. Circulation 2009;119:2995-3001. https://doi.org/10.1161/CIRCULATIONAHA.108.836312
  22. Cubeddu RJ, Hijazi ZM. Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards Sapien transcatheter heart valve. Catheter Cardiovasc Interv 2011;77:276-80. https://doi.org/10.1002/ccd.22653
  23. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and mediumterm outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507-16. https://doi.org/10.1161/CIRCULATIONAHA.109.921692
  24. Sridharan S, Coats L, Khambadkone S, Taylor AM, Bonhoeffer P. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation. Circulation 2006; 113:e934-5. https://doi.org/10.1161/CIRCULATIONAHA.105.599514
  25. Biermann D, Schonebeck J, Rebel M, Weil J, Dodge-Khatami A. Left coronary artery occlusion after percutaneous pulmonary valve implantation. Ann Thorac Surg 2012;94:e7-9. https://doi.org/10.1016/j.athoracsur.2012.01.022
  26. Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-72. https://doi.org/10.1161/CIRCULATIONAHA.107.735779
  27. Nordmeyer J, Coats L, Lurz P, et al. Percutaneous pulmonary valve-invalve implantation: a successful treatment concept for early device failure. Eur Heart J 2008;29:810-5. https://doi.org/10.1093/eurheartj/ehn073
  28. Vezmar M, Chaturvedi R, Lee KJ, et al. Percutaneous pulmonary valve implantation in the young 2-year follow-up. JACC Cardiovasc Interv 2010;3:439-48. https://doi.org/10.1016/j.jcin.2010.02.003
  29. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189-97. https://doi.org/10.1161/CIRCULATIONAHA.104.523266
  30. McElhinney DB, Cheatham JP, Jones TK, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv 2011;4:602-14. https://doi.org/10.1161/CIRCINTERVENTIONS.111.965616

Cited by

  1. Polymer-Based Reconstruction of the Inferior Vena Cava in Rat: Stem Cells or RGD Peptide? vol.21, pp.9, 2012, https://doi.org/10.1089/ten.tea.2014.0254
  2. Successful Feasibility Human Trial of a New Self-Expandable Percutaneous Pulmonary Valve (Pulsta Valve) Implantation Using Knitted Nitinol Wire Backbone and Trileaflet α-Gal–Free Porcine vol.11, pp.6, 2018, https://doi.org/10.1161/circinterventions.118.006494